Aaron J. Kowalski

Chief Executive Officer Aaron J. Kowalski, Ph.D., drives strategies to advance Breakthrough T1D’s mission to cure, prevent, and treat T1D and its complications. Dr. Kowalski joined the organization in 2004 and held the position of Chief Mission Officer before assuming his current role as CEO, leading Breakthrough T1D’s research and advocacy strategy. Dr. Kowalski is an internationally recognized scientific expert in T1D research. He has also served as a policy leader for the organization, regularly advising Congress, the U.S. Department of Health and Human Services, and the U.S. Food and Drug Administration. Dr. Kowalski’s scientific expertise, personal experience living with T1D for more than 35 years, and his ability to engage the T1D community enable him to lead Breakthrough T1D in our path to cures.